Cargando…
The more the messier: centrosome amplification as a novel biomarker for personalized treatment of colorectal cancers
Colon cancer is currently the third most common cancer and second most fatal cancer in the United States, resulting in approximately 600,000 deaths annually. Though colorectal cancer death rates are decreasing by about 3% every year, disease outcomes could be substantially improved with more researc...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Editorial Department of Journal of Biomedical Research
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5138576/ https://www.ncbi.nlm.nih.gov/pubmed/27924065 http://dx.doi.org/10.7555/JBR.30.20150109 |